IDiyas

For the Inventor, By the Inventor

Thiais, France

Hervé Bouchard

USPTO Granted Patents = 15 

 

Average Co-Inventor Count = 4.9

ph-index = 6

Forward Citations = 141(Granted Patents)


Location History:

  • Ivry sur Seine, FR (2006)
  • Paris, FR (2013 - 2022)
  • Thiais, FR (2005 - 2024)

Company Filing History:

goldMedal8 out of 1,451 
 
Sanofi
 patents
silverMedal7 out of 377 
 
Aventis Pharma S.a.
 patents

Years Active: 2005-2024

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents
1. 11998611 - Cryptophycin antibody conjugates for the treatment of cancer (2024-06-04),
2. 11332542 - Anti-CEACAM5 antibodies and uses thereof (2022-05-17),
3. 11007275 - Cryptophycin antibody conjugates for the treatment of cancer (2021-05-18),
4. 10941139 - Cryptophycin compounds and conjugates, their preparation and their therapeutic use (2021-03-09),
5. 10457739 - Anti-CEACAM5 antibodies and uses thereof (2019-10-29),
6. 9617345 - Anti-CEACAM5 antibodies and uses thereof (2017-04-11),
7. 8952147 - Conjugates, preparation thereof, and therapeutic use thereof (2015-02-10),
8. 8404678 - Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use (2013-03-26),
9. 7759379 - Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors (2010-07-20),
10. 7517902 - Substituted indazoles, compositions containing the same, and the preparation and use thereof (2009-04-14),
11. 7109340 - Substituted tetrahydro-1H-pyrazolo [3,4-c] pyridines, compositions comprising them, and use (2006-09-19),
12. 7074821 - Taxoids, their preparation and pharmaceutical composition containing them (2006-07-11),
13. 6995175 - Chemical derivatives and their application as antitelomerase agent (2006-02-07),
14. 6872717 - Pharmacological uses of azetidine derivatives (2005-03-29),
15. 6858603 - Acetindine derivatives, their preparation and medicaments containing them (2005-02-22),

Title: Hervé Bouchard: Innovator in Cancer Treatment

Introduction

Hervé Bouchard is a prominent inventor based in Thiais, France, known for his significant contributions to the field of cancer treatment. With a total of 15 patents to his name, Bouchard has made remarkable strides in developing innovative therapeutic solutions.

Latest Patents

Among his latest patents are "Cryptophycin antibody conjugates for the treatment of cancer," which focuses on cryptophycin conjugates designed to combat cancer effectively. Another notable patent is "Anti-CEACAM5 antibodies and uses thereof," which discloses antibodies that bind to human CEACAM5 proteins. This patent also includes isolated nucleic acids, vectors, and host cells that encode these antibodies. The immunoconjugates developed from these antibodies are intended for both cancer treatment and diagnostic purposes.

Career Highlights

Bouchard has had a distinguished career, working with leading pharmaceutical companies such as Sanofi and Aventis Pharma. His work has been instrumental in advancing cancer therapies, showcasing his dedication to improving patient outcomes through innovative research.

Collaborations

Throughout his career, Bouchard has collaborated with notable professionals, including Marie-Priscille Brun and Augustin Hittinger. These partnerships have contributed to the success of his research and the development of groundbreaking treatments.

Conclusion

Hervé Bouchard

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…